January 21, 2026 05:28 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Twist before Tamil Nadu polls! TTV Dhinakaran returns to NDA after bitter exit | Gold goes berserk! Prices smash all-time high as global tensions explode | Markets end in red: Sensex slips 271 points, Nifty below 25,200; rupee hits record low | Nitin Nabin becomes BJP’s youngest president ahead of key assembly polls, PM Modi calls him ‘my boss’ | Viral video scandal rocks Karnataka Police: DGP Ramachandra Rao suspended | Jolt to ECI over SIR! SC allows BLAs at hearing, questions 'logical discrepancy'; TMC declares 'BJP's game over' | Will dal disrupt diplomacy? US lawmakers urge Trump to act on India’s 30% pulse tariff | 'Pakistan deserves Operation Sindoor 2.0', says Baloch leader over Trump’s Gaza board invitation to Islamabad | From Malda to the nation: PM Modi unveils India’s Vande Bharat sleeper | War zone Beldanga: Highway blocked, reporters attacked in migrant death protests
COVID19
Pixabay

US centers for disease control backs panel proposal for initial COVID-19 vaccine doses

| @indiablooms | Dec 04, 2020, at 02:59 pm

Washington/Sputnik: The US Centers for Disease Control and Prevention (CDC) adopted recommendations from an advisory panel that the first doses of a coronavirus vaccine be reserved for elderly care residents and health workers, according to a press release.

''[CDC Director Robert] Redfield supports their recommendations and has signed the memo and accepted these interim recommendations,'' the release said on Thursday.

On Tuesday, the CDC’s Advisory Committee on Immunization Practices recommended that initial vaccinations target 3 million residents in elderly care facilities and a portion of the nation’s 21 million healthcare workers.

Health workers such as nurses, whose jobs routinely place them within six feet of other people, would be first to receive the vaccine followed by workers able to follow CDC social distancing guidelines, the Advisory Committee said.

Vaccines made by Pfizer and Moderna have applied for emergency use authorization from the US Food and Drug Administration amid expectations of quick approval with first doses administered later this month. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.